In a patient with a hyperglycemic hyperosmolar state who is undergoing vigorous rehydration and IV insulin, when should glucose be added to the IV fluids?

In a patient with a hyperglycemic hyperosmolar state who is undergoing vigorous rehydration and IV insulin, when should glucose be added to the IV fluids?

• A. When stable
• B. When urine output reaches 50 mL/hour
• C. When blood glucose reaches 250 mg/dL
• D. If hypokalemia develops

Answer: (C)

When treating a hyperglycemic hyperosmolar state with aggressive hydration and insulin, you continue to provide glucose as you continue to insulinize so you don’t drive the blood sugar too low. The practical moment to do this is when the blood glucose level falls to about 250 mg/dL. At that point you switch to a dextrose-containing IV fluid while maintaining the insulin infusion, so you can keep correcting hyperglycemia and osmolarity without risking hypoglycemia. This threshold helps balance ongoing insulin-driven glucose clearance with a steady supply of glucose to keep levels safe. Why the other options aren’t used: waiting for “stability” isn’t specific enough to prevent hypoglycemia during ongoing insulin therapy; urine output is a hydration and perfusion marker, not a trigger for glucose supplementation; and addressing hypokalemia is important during insulin therapy, but it doesn’t dictate when to add glucose—the glucose switch is driven by the current blood glucose level, not potassium status.

When treating a hyperglycemic hyperosmolar state with aggressive hydration and insulin, you continue to provide glucose as you continue to insulinize so you don’t drive the blood sugar too low. The practical moment to do this is when the blood glucose level falls to about 250 mg/dL. At that point you switch to a dextrose-containing IV fluid while maintaining the insulin infusion, so you can keep correcting hyperglycemia and osmolarity without risking hypoglycemia. This threshold helps balance ongoing insulin-driven glucose clearance with a steady supply of glucose to keep levels safe.

Why the other options aren’t used: waiting for “stability” isn’t specific enough to prevent hypoglycemia during ongoing insulin therapy; urine output is a hydration and perfusion marker, not a trigger for glucose supplementation; and addressing hypokalemia is important during insulin therapy, but it doesn’t dictate when to add glucose—the glucose switch is driven by the current blood glucose level, not potassium status.